HOG News and Press, Harley-Davidson Inc. From 11/04/19

KeyBanc lowers its rating on Harley-Davidson ( HOG -0.5% ) after channel checks indicate deteriorating new and used conditions. More news on: Harley-Davidson, Inc., Consumer stocks news, Stocks on the move, Read more ...

Through the last few years, Harley-Davidson (NYSE: HOG) has suffered. The sales environment has been tough for the maker of classic American motorcycles, as shifting consumer preferences and its relatively high prices have driven customers elsewhere. Based on the latest earnings report, r...

Harley-Davidson (NYSE: HOG) posted surprisingly better sales numbers in the third quarter than analysts expected, though they still fell, and profits plunged 24% from the year-ago period. The motorcycle giant's less-bad results don't mean it's regaining its balance, regardless of what manag...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . A slowdown warning from Texas Instruments (TXN) and widened antitrust probe into Facebook (FB) weighed on the tech sector overnigh...

Image source: The Motley Fool. Harley-Davidson   (NYSE: HOG) Q3 2019 Earnings Call Oct 22, 2019 , 9:00 a.m. ET Operator Continue reading

Shares of motorcycle icon Harley-Davidson (NYSE: HOG) jumped as much as 9.5% today on better-than-expected earnings results. At 2:30 p.m. EDT, shares were still up 9.3% and gaining for the day. Revenue fell 4.9% to $1.07 billion as motorcycle unit volume declined 1.2% to 58,522 in the third...

Harley-Davidson, Inc. (NYSE:HOG) Q3 2019 Earnings Conference Call October 22, 2019 9:00 AM ET Company Participants Shannon Burns - Director-Investor Relations Matt Levatich - President and Chief Executive Officer John Olin - Chief Financial Officer Conference Call Participan...

Trader Truism: there is no such thing as a "Triple Top" This is not a law of physics and, of course, you can find plenty of examples of an index hitting a high multiple times and then rolling over. The point is, this is a rule of thumb, the more times market participants contend with an ov...

TrovaGene (NASDAQ: TROV ) +56%  on positive response to treatment in phase 1b/2 trial of onvansertib in patients with KRAS-mutated metastatic colorectal cancer. More news on: TrovaGene, Inc., Biogen Inc., Stamps.com Inc., Stocks on the move, Read more ...

The following slide deck was published by Harley-Davidson, Inc. in conjunction with their 2019 Q3 earnings Read more ...